Browsing Category
Uncategorized
HiFiBiO Therapeutics Inks Partnership with Pharmsynthez and IBCh for the Clinical Development and…
HiFiBiO Therapeutics, a multinational biotherapeutics company with unique expertise in immune modulation and single cell science, announced a…
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine…
Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing therapies to…
Insight into the Latest Developments in Oligonucleotide Delivery Systems
SMi Reports: A Focus Day has been added to SMi’s RNA Therapeutics Conference, which will highlight the recent developments in "Oligonucleotide…
DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy
DelSiTech Ltd and Innovare R&D have signed a world-wide, exclusive licence agreement for the use of DelSiTech’s Silica Matrix drug delivery…
Dr. Warren Krackov appointed Medical Director and UFE Specialist for Vascular Interventions
Dr. Warren Krackov, interventional radiologist specializing in minimally invasive treatment for dialysis access management and other vascular…